Women who filled a prescription for female hormone therapy did not have an increased risk for retinal vein occlusion or retinal artery occlusion, according to findings published in JAMA Ophthalmology.
“Given that retinal vascular occlusions share similar risk factors to those of cardiovascular and cerebrovascular diseases, it is therefore reasonable to suspect the FHT may predispose toward retinal vascular occlusion,” Delu Song, MD, and colleagues wrote.
However, no significant association was found between filling a prescription for female hormone therapy (FHT) and all outcomes
Uncategorized